News
The number of new HIV diagnoses is on the rise among heterosexual men in Australia, according to a new report released by the Kirby Institute.
Sarepta Therapeutics has revealed that its therapy Exondys 51 (eteplirsen) has been slapped with a negative opinion by the European Medicines...
The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block Britain’s National...
Life expectancy has fallen for the second year in a row for people in the United States, according to new data released by Centers for...
AstraZeneca has unveiled new Phase 3 data for its SGLT2 inhibitor Farxiga (dapagliflozin), showing with the drug demonstrating positive findings in...
The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing...
To find out more, check out this week’s Top 10 most popular articles on Pharmafile.com now!
The Association of the British Pharmaceutical Industry (ABPI) has announced that it is forging a five year partnership with the Academic Health...
PrEP drugs – pre-sex drugs that are able to dramatically reduce the chances a person has of contracting HIV – should be made available on the NHS,...
The Surgeon General of the United States has called for a cultural shift in the way in which Americans talk about the opioid crisis after...
